Navigation Links
MAP Pharmaceuticals to Present at the Deutsche Bank Securities 34th Annual Health Care Conference
Date:5/13/2009

MOUNTAIN VIEW, Calif., May 13 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that the company will present at the Deutsche Bank Securities 34th Annual Health Care Conference on Tuesday, May 19, 2009 at 2:35 p.m. (ET) in Boston, MA.

A live webcast of the presentation will be available on the Investor Relations section of MAP Pharmaceuticals' website at http://www.mappharma.com. A replay will also be available within 24 hours for seven days following the presentation.

About MAP Pharmaceuticals

MAP Pharmaceuticals is dedicated to developing and commercializing new therapies for children and adults suffering from chronic conditions that are not adequately treated by currently available medicines. The company has two product candidates in Phase 3 clinical development. Unit Dose Budesonide is being developed in collaboration with AstraZeneca for the potential treatment of asthma in children, and MAP0004 is being developed for the potential treatment of migraine. In addition, MAP Pharmaceuticals generates new pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk, by capitalizing on their known safety, efficacy and commercialization history.

Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com.

    Contact:
    Lisa Borland
    650-386-3122


'/>"/>
SOURCE MAP Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... San Diego, CA (PRWEB) May 26, 2015 ... medical director, launched and directed a hospital-wide Patient Blood ... in Bangor that reduced overall blood usage by more ... five-year period. , Covered in detail in an ... PBM program resulted in substantially reduced perioperative red cell ...
(Date:5/26/2015)... CO (PRWEB) May 26, 2015 It ... diverse community foundation in Colorado. On Wednesday, May 13, ... ushered in a new era of community-based giving with ... Titled “Our Future in the Making,” the event celebrated ... The Denver Foundation to mobilize resources for good. , ...
(Date:5/26/2015)... Relias Learning , the leader in online ... services market, announces expansion of their user group sessions ... participation in 2014, they will double the number of ... an exciting new facelift. , Regional user group ... best practices, share their expertise, provide feedback directly to ...
(Date:5/26/2015)... 26, 2015 CIO Review has chosen ... Pharma and Life Sciences Technology Solution Providers. The positioning is ... compliant solution which is applicable across the entire security spectrum ... for broad adoption. , “SIGNiX has been on our ... Pharma and Life Sciences Technology space, and we are happy ...
(Date:5/26/2015)... Indosoft, Inc ., developer of ... DMi Partners contact center to Q-Suite 5.8 call ... contact center ACD system to drop Asterisk 1.4 support. ... trunk features as diversion headers, added Lyra support via ... to warm transfers to improve information handling ...
Breaking Medicine News(10 mins):Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 2Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 3Health News:Celebrating "Our Future in the Making" 2Health News:Celebrating "Our Future in the Making" 3Health News:Relias Learning Expands User Groups and Industry Influence 2Health News:Relias Learning Expands User Groups and Industry Influence 3Health News:CIO Review Selects SIGNiX as a 20 Most Promising Pharma and Life Sciences Technology Solution Provider in 2015 2Health News:CIO Review Selects SIGNiX as a 20 Most Promising Pharma and Life Sciences Technology Solution Provider in 2015 3Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 3
... , CRANBURY, N.J., Sept. 10 Amicus ... and chief executive officer, John F. Crowley, will be presenting at the ... scheduled to begin on Monday, September 14 at 5:05 p.m. EDT. , ... the presentation by logging on to the Investors section of the Amicus ...
... Sept. 10 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: ... global life sciences markets, today reported financial results for the three-month ... million, a net loss of $62 million and a loss per ... $252 million in total revenue, a net loss of $10 million ...
... , , CAMBRIDGE, ... ISIS ) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ... Office (USPTO) has allowed an Isis patent application that further expands ... patent broadly covers methods of cleaving a target RNA via a ...
... , , , ST. ... ) announced that Novation, the leading health care supply contracting ... systems to its capital products contract portfolio. This is ... robotic interventional technology among Novation,s capital products offerings. This ...
... , SAN DIEGO, Sept. 10 The American ... to educate individuals and couples about their family-building options in a ... 21st. Those who attend Dessert & Learn La Jolla ... Law, about third party reproduction options like egg donation, sperm donation, ...
... (OTCBB: GVBP.OB) - GENova Biotherapeutics, Inc., ("GENova"), a biotechnology ... that disrupt the advance of life-threatening diseases, today announced ... drug target that combats breast cancer. , The target, ... death in breast cancer cells, thus curtailing development of ...
Cached Medicine News:Health News:MDS Reports Third Quarter 2009 Financial Results 2Health News:MDS Reports Third Quarter 2009 Financial Results 3Health News:MDS Reports Third Quarter 2009 Financial Results 4Health News:MDS Reports Third Quarter 2009 Financial Results 5Health News:MDS Reports Third Quarter 2009 Financial Results 6Health News:MDS Reports Third Quarter 2009 Financial Results 7Health News:MDS Reports Third Quarter 2009 Financial Results 8Health News:MDS Reports Third Quarter 2009 Financial Results 9Health News:MDS Reports Third Quarter 2009 Financial Results 10Health News:MDS Reports Third Quarter 2009 Financial Results 11Health News:MDS Reports Third Quarter 2009 Financial Results 12Health News:MDS Reports Third Quarter 2009 Financial Results 13Health News:MDS Reports Third Quarter 2009 Financial Results 14Health News:MDS Reports Third Quarter 2009 Financial Results 15Health News:MDS Reports Third Quarter 2009 Financial Results 16Health News:MDS Reports Third Quarter 2009 Financial Results 17Health News:MDS Reports Third Quarter 2009 Financial Results 18Health News:MDS Reports Third Quarter 2009 Financial Results 19Health News:MDS Reports Third Quarter 2009 Financial Results 20Health News:MDS Reports Third Quarter 2009 Financial Results 21Health News:MDS Reports Third Quarter 2009 Financial Results 22Health News:MDS Reports Third Quarter 2009 Financial Results 23Health News:Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology 2Health News:Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology 3Health News:Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology 4Health News:Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology 5Health News:Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology 6Health News:Stereotaxis Awarded Exclusive Contract by Novation for Robotic Interventional Technology 2Health News:Stereotaxis Awarded Exclusive Contract by Novation for Robotic Interventional Technology 3Health News:Stereotaxis Awarded Exclusive Contract by Novation for Robotic Interventional Technology 4Health News:Innovative Program Educates Hopeful Parents on Third Party Reproduction 2Health News:Innovative Program Educates Hopeful Parents on Third Party Reproduction 3Health News:GENova files patent for new breast cancer treatment 2
(Date:5/26/2015)... May 26, 2015 Boston Scientific Corporation (NYSE: ... 36 th Annual Global Healthcare Conference on June 9 ... Dan Brennan , executive vice president and chief ... Relations, will participate in a 35-minute question and answer session ... 10 a.m. PT. A live webcast of the ...
(Date:5/26/2015)... 2015 Xencor, Inc. (NASDAQ: XNCR ), ... the treatment of autoimmune diseases, asthma and allergic diseases, ... President and Chief Executive Officer, will present at the ... at 8:30 a.m. ET in New York ... of the presentation will be available on the "Events ...
(Date:5/26/2015)... 26, 2015  Northstar Global Business Services, Inc. ... a deal with Mr. Checkout, a national distribution ... product, SNORenz to brick and mortar retail stores. ... cross section of about fifty convenience stores, pharmacies, ... valuable statistics during the lead time the company ...
Breaking Medicine Technology:Boston Scientific To Participate In The Goldman Sachs 36th Annual Global Healthcare Conference 2Xencor to Present at Jefferies 2015 Healthcare Conference 2Northstar announces in-store rollout deal with national distribution group reaching more than 35,000 stores nationwide 2Northstar announces in-store rollout deal with national distribution group reaching more than 35,000 stores nationwide 3
... and PARIS , July 19 Corgenix Medical Corporation ... kits, and the ELITech Group, a Paris, France -based, privately held ... and reagents, today announced a broad strategic alliance. Terms of the agreement ... ...
... , ZURICH , July 19, 2010 ... - an,observational study designed to investigate the effects of modern insulins in,the management of ... Spanning ... be the world,s largest observational study,in insulin therapy. , ...
Cached Medicine Technology:Corgenix Medical Corp. and the ELITech Group Establish Strategic Alliance 2Corgenix Medical Corp. and the ELITech Group Establish Strategic Alliance 3Corgenix Medical Corp. and the ELITech Group Establish Strategic Alliance 4World's Largest Study on Insulin Therapy Completes Recruitment With 60,000 Patients 2World's Largest Study on Insulin Therapy Completes Recruitment With 60,000 Patients 3
Inquire...
Inquire...
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available....
Inquire...
Medicine Products: